Related Experiment Video
Updated: Jan 10, 2026
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Evaluation of a rapid flow cytometry assay to assess functional engraftment in CGD patients post-transplant and
Lan Mai1, Caleb Cornaby2, Lee Ann Baxter-Lowe2
1Department of Molecular and Cell Biology, University of California, Berkeley, CA, United States of America.
This study explores the value of the Dihydrorhodamine-123 (DHR-123) flow cytometry assay to rapidly measure donor neutrophil engraftment (chimerism) in patients with Chronic Granulomatous Disease (CGD) following hematopoietic stem cell transplant (HSCT). Flow cytometry-based chimerism testing was compared with traditional molecular methods including sequence tandem repeats (STR), Quantitative-PCR DNA fingerprinting, and next-generation sequencing (NGS). Results comparing the two technologies in a cohort of CGD patients and healthy control subjects demonstrated that the DHR-123 based flow cytometry chimerism assay is an accurate, inexpensive, and rapid method for assessing functional donor neutrophil engraftment post-transplant, and which demonstrated significant correlation with the results of the molecular chimerism assays (R2 = 0.9965), making it a valuable tool for ongoing chimerism monitoring post-transplant. The flow cytometry-based assay offers a more rapid and inexpensive alternative to traditional molecular chimerism techniques.
This study explores the value of the Dihydrorhodamine-123 (DHR-123) flow cytometry assay to rapidly measure donor neutrophil engraftment (chimerism) in patients with Chronic Granulomatous Disease (CGD) following hematopoietic stem cell transplant (HSCT). Flow cytometry-based chimerism testing was compared with traditional molecular methods including sequence tandem repeats (STR), Quantitative-PCR DNA fingerprinting, and next-generation sequencing (NGS). Results comparing the two technologies in a cohort of CGD patients and healthy control subjects demonstrated that the DHR-123 based flow cytometry chimerism assay is an accurate, inexpensive, and rapid method for assessing functional donor neutrophil engraftment post-transplant, and which demonstrated significant correlation with the results of the molecular chimerism assays (R2 = 0.9965), making it a valuable tool for ongoing chimerism monitoring post-transplant. The flow cytometry-based assay offers a more rapid and inexpensive alternative to traditional molecular chimerism techniques.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
10:11Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
Published on: March 7, 2013